jrnl4909

Publication Venue For

  • 2020 American College of Rheumatology Guideline for the Management of Gout. 2020
  • Reply..  72:736-738. 2020
  • 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.  72:461-488. 2020
  • Assessing Rheumatoid Arthritis Disease Activity With Patient-Reported Outcomes Measurement Information System Measures Using Digital Technology.  72:553-560. 2020
  • Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.  72:561-576. 2020
  • 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.  72:149-162. 2020
  • Do Patients With Moderate or High Disease Activity Escalate Rheumatoid Arthritis Therapy According to Treat-to-Target Principles? Results From the Rheumatology Informatics System for Effectiveness Registry of the American College of Rheumatology.  72:166-175. 2020
  • Association of Diabetes Mellitus and Biomarkers of Abnormal Glucose Metabolism With Incident Radiographic Knee Osteoarthritis.  72:98-106. 2020
  • Step Rate and Worsening of Patellofemoral and Tibiofemoral Joint Osteoarthritis in Women and Men: The Multicenter Osteoarthritis Study.  72:107-113. 2020
  • 2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures.  71:1540-1555. 2019
  • Association of Short-Term Ultraviolet Radiation Exposure and Disease Severity in Juvenile Dermatomyositis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.  71:1600-1605. 2019
  • International Consortium for Health Outcome Measurement Set of Outcomes That Matter to People Living With Inflammatory Arthritis: Consensus From an International Working Group.  71:1556-1565. 2019
  • Screening of Hyperlipidemia Among Patients With Rheumatoid Arthritis in the United States.  71:1593-1599. 2019
  • Sex Differences in Quality of Life in Patients With Systemic Lupus Erythematosus.  71:1647-1652. 2019
  • 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.  71:1285-1299. 2019
  • Association of Varus Knee Thrust During Walking With Worsening Western Ontario and McMaster Universities Osteoarthritis Index Knee Pain: A Prospective Cohort Study.  71:1353-1359. 2019
  • Low Persistence Rates in Patients With Rheumatoid Arthritis Treated With Triple Therapy and Adverse Drug Events Associated With Sulfasalazine.  71:1326-1335. 2019
  • Sex-Specific Influence of Quadriceps Weakness on Worsening Patellofemoral and Tibiofemoral Cartilage Damage: A Prospective Cohort Study.  71:1360-1365. 2019
  • Risk for Herpes Zoster in Tofacitinib-Treated Rheumatoid Arthritis Patients With and Without Concomitant Methotrexate and Glucocorticoids.  71:1249-1254. 2019
  • Thresholds in the Relationship of Quadriceps Strength With Functional Limitations in Women With Knee Osteoarthritis.  71:1186-1193. 2019
  • Timing of Abatacept Before Elective Arthroplasty and Risk of Postoperative Outcomes.  71:1224-1233. 2019
  • Concurrent Change in Quadriceps Strength and Physical Function Over Five Years in the Multicenter Osteoarthritis Study.  71:1044-1051. 2019
  • Long-Term Safety of Rituximab in Patients With Rheumatoid Arthritis: Results of a Five-Year Observational Study.  71:993-1003. 2019
  • Tocilizumab and the Risk of Cardiovascular Disease: Direct Comparison Among Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Patients.  71:1004-1018. 2019
  • Antinuclear Antibody–Negative Systemic Lupus Erythematosus in an International Inception Cohort.  71:893-902. 2019
  • 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis.  71:703-716. 2019
  • 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.  71:717-734. 2019
  • American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus.  71:579-590. 2019
  • Patient- and Rheumatologist- Perspectives Regarding Challenges to Achieving Optimal Disease Control in Rheumatoid Arthritis. 2019
  • Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout.  71:427-434. 2019
  • A Novel Method to Combine Assessment of Benefit and Harm: Outcome Measures in Rheumatology 3×3 Methodology Applied to Two Active Comparator Trials.  71:319-322. 2019
  • Chronic Inflammation in Rheumatoid Arthritis and Mediators of Skeletal Muscle Pathology and Physical Impairment: A Review.  71:173-177. 2019
  • Childhood arthritis and rheumatology research alliance consensus treatment plans for juvenile idiopathic arthritis–Associated and idiopathic chronic anterior uveitis.  71:482-491. 2019
  • Perspectives of Rheumatoid Arthritis Patients on Electronic Communication and Patient-Reported Outcome Data Collection: A Qualitative Study.  71:80-87. 2019
  • Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.  71:2-29. 2019
  • Clinical Characteristics and Factors Associated With Disability and Impaired Quality of Life in Children With Juvenile Systemic Sclerosis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.  70:1806-1813. 2018
  • Is Rheumatoid Arthritis a Cardiovascular Risk-Equivalent to Diabetes Mellitus?.  70:1694-1699. 2018
  • Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot Study.  70:1653-1660. 2018
  • Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.  70:1478-1487. 2018
  • Evaluation of a Methodologic Approach to Define an Inception Cohort of Rheumatoid Arthritis Patients Using Administrative Data.  70:1541-1545. 2018
  • Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach.  70:1294-1302. 2018
  • Development of the American College of Rheumatology Electronic Clinical Quality Measures for Gout.  70:659-671. 2018
  • Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis.  70:679-684. 2018
  • Toward Establishing a Standardized Magnetic Resonance Imaging Scoring System for Temporomandibular Joints in Juvenile Idiopathic Arthritis.  70:758-767. 2018
  • Affect and Incident Participation Restriction in Adults With Knee Osteoarthritis.  70:542-549. 2018
  • Delays to Care in Pediatric Lupus Patients: Data From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.  70:420-427. 2018
  • Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.  70:409-419. 2018
  • Development and Pilot Testing of Multimedia Patient Education Tools for Patients With Knee Osteoarthritis, Osteoporosis, and Rheumatoid Arthritis.  70:213-220. 2018
  • Septic Arthritis in Emergency Departments in the US: A National Study of Health Care Utilization and Time Trends.  70:320-326. 2018
  • Perioperative Timing of Infliximab and the Risk of Serious Infection After Elective Hip and Knee Arthroplasty.  69:1845-1854. 2017
  • Gout Self-Management in African American Veterans: A Qualitative Exploration of Challenges and Solutions From Patients' Perspectives.  69:1724-1732. 2017
  • Serious Infections in Childhood-Onset Systemic Lupus Erythematosus: Using Administrative Claims Data to Investigate Disease Outcomes.  69:1617-1619. 2017
  • Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis.  69:1526-1534. 2017
  • Calcium Pyrophosphate Deposition Disease and Associated Medical Comorbidities: A National Cross-Sectional Study of US Veterans.  69:1400-1406. 2017
  • 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.  69:1111-1124. 2017
  • Clinical Practice Guidelines: Incorporating Input From a Patient Panel.  69:1125-1130. 2017
  • Association of Anti–3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.  69:1088-1094. 2017
  • Perceived Community Environmental Factors and Risk of Five-Year Participation Restriction Among Older Adults With or at Risk of Knee Osteoarthritis.  69:952-958. 2017
  • Knee Pain and Structural Damage as Risk Factors for Incident Widespread Pain: Data From the Multicenter Osteoarthritis Study.  69:826-832. 2017
  • Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis.  69:313-322. 2017
  • Cost-Effectiveness Analysis of First-Line Treatment With Biologic Agents in Polyarticular Juvenile Idiopathic Arthritis.  68:1803-1811. 2016
  • Cost-Effectiveness of Triple Therapy Versus Etanercept Plus Methotrexate in Early Aggressive Rheumatoid Arthritis.  68:1751-1757. 2016
  • Mapping Perceptions of Lupus Medication Decision-Making Facilitators: The Importance of Patient Context.  68:1787-1794. 2016
  • Development of the American College of Rheumatology’s Rheumatoid Arthritis Electronic Clinical Quality Measures.  68:1579-1590. 2016
  • Effect of Knee Extensor Strength on Incident Radiographic and Symptomatic Knee Osteoarthritis in Individuals With Meniscal Pathology: Data From the Multicenter Osteoarthritis Study.  68:1640-1646. 2016
  • Are Pressure Time Integral and Cumulative Plantar Stress Related to First Metatarsophalangeal Joint Pain? Results From a Community-Based Study.  68:1232-1238. 2016
  • Treatment Algorithms for Patients with Systemic Lupus Erythematosus: Comment on the Article by Muangchan et al.  68:1385. 2016
  • Symptoms of Knee Instability as Risk Factors for Recurrent Falls.  68:1089-1097. 2016
  • Relation of Step Length to Magnetic Resonance Imaging-Detected Structural Damage in the Patellofemoral Joint: The Multicenter Osteoarthritis Study.  68:776-783. 2016
  • Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises.  68:667-672. 2016
  • Reply.  68:725-726. 2016
  • Enhanced Pain Sensitivity among Individuals with Symptomatic Knee Osteoarthritis: Potential Sex Differences in Central Sensitization.  68:472-480. 2016
  • Exercise Medicine for Osteoarthritis: Research Strategies to Maximize Effectiveness.  68:288-291. 2016
  • Incomplete Systemic Lupus Erythematosus: Early Diagnosis or Overdiagnosis?.  68:285-287. 2016
  • Longitudinal Course of Physical Function in People with Symptomatic Knee Osteoarthritis: Data from the Multicenter Osteoarthritis Study and the Osteoarthritis Initiative.  68:325-331. 2016
  • When Patients Write the Guidelines: Patient Panel Recommendations for the Treatment of Rheumatoid Arthritis.  68:26-35. 2016
  • Herpes Zoster Reactivation in Patients with Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease-Modifying Antirheumatic Drugs.  67:1671-1678. 2015
  • Can an intensive diet and exercise program prevent knee pain among overweight adults at high risk?.  67:965-971. 2015
  • 20-Year-Old Amish Woman With Abdominal Pain, Retroperitoneal Mass, and Hyperlipidemia.  67:447-451. 2015
  • Comprehensive appraisal of magnetic resonance imaging findings in sustained rheumatoid arthritis remission: A substudy.  67:929-939. 2015
  • Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients.  67:1345-1353. 2015
  • Does hospital volume predict outcomes and complications after total shoulder arthroplasty in the US?.  67:885-890. 2015
  • Electrocardiographic findings in systemic lupus erythematosus: Data from an international inception cohort.  67:128-135. 2015
  • Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients.  67:624-632. 2015
  • Novel method to collect medication adverse events in juvenile arthritis: Results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance project.  67:529-537. 2015
  • Proceedings from the American College of Rheumatology Reproductive Health Summit: The management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases.  67:313-325. 2015
  • Racial and Ethnic Differences in Mortality and Cardiovascular Events among Patients with End-Stage Renal Disease Due to Lupus Nephritis.  67:1453-1462. 2015
  • Reply.  67:1041-1042. 2015
  • Rheumatoid arthritis is associated with higher ninety-day hospital readmission rates compared to osteoarthritis after hip or knee arthroplasty: A cohort study.  67:718-724. 2015
  • Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy.  67:731-736. 2015
  • What is the relationship between morning symptoms and measures of disease activity in patients with rheumatoid arthritis?.  67:1202-1209. 2015
  • Use of Oral and Subcutaneous Methotrexate in Rheumatoid Arthritis Patients in the United States.  66:1604-1611. 2014
  • Complementary and alternative medicine use in African Americans with rheumatoid arthritis.  66:180-189. 2014
  • Adding canakinumab to the childhood arthritis and rheumatology research alliance consensus treatment plans for systemic juvenile idiopathic arthritis: Comment on the article by DeWitt et al.  66:1430-1431. 2014
  • Changes in quality of life in the first 5 years of disease in a multicenter cohort of patients with systemic lupus erythematosus.  66:1374-1379. 2014
  • Daily walking and the risk of incident functional limitation in knee osteoarthritis: An observational study.  66:1328-1336. 2014
  • Development and retrospective validation of the juvenile spondyloarthritis disease activity index.  66:1775-1782. 2014
  • Development and validation of the lupus impact tracker: A patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus.  66:1542-1550. 2014
  • Imaging of the temporomandibular joint in juvenile idiopathic arthritis.  66:47-54. 2014
  • Linkage of a de-identified united states rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research.  66:1790-1798. 2014
  • Reply.  66:1271-1272. 2014
  • Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritis.  66:990-997. 2014
  • Socioeconomic disparities in the health of African Americans with rheumatoid arthritis from the southeastern United States.  66:1808-1817. 2014
  • Time trends in the characteristics of patients undergoing primary total knee arthroplasty.  66:897-906. 2014
  • Better functional and similar pain outcomes in osteoarthritis compared to rheumatoid arthritis after primary total knee arthroplasty: A cohort study.  65:1936-1941. 2013
  • Psychological profiles and pain characteristics of older adults with knee osteoarthritis.  65:1786-1794. 2013
  • Tumor necrosis factor, tuberculosis, testing, and treatment: Teeing up the questions.  65:1719-1721. 2013
  • Tumor necrosis factor, tuberculosis, testing, and treatment: teeing up the questions..  65:1719-1721. 2013
  • 2013 Update of the 2011 American college of rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.  65:1551-1563. 2013
  • Patient perspectives on achieving treat-to-target goals: A critical examination of patient-reported outcomes.  65:1707-1712. 2013
  • Serum urate levels and consumption of common beverages and alcohol among chinese in Singapore.  65:1432-1440. 2013
  • Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases.  65:1085-1094. 2013
  • Sex and surgical outcomes and mortality after primary total knee arthroplasty: A risk-adjusted analysis.  65:1095-1102. 2013
  • Clinically important body weight gain following knee arthroplasty: A five-year comparative cohort study.  65:669-677. 2013
  • Reply.  65:832-833. 2013
  • Gout-related health care utilization in US emergency departments, 2006 through 2008.  65:571-577. 2013
  • Physicians' explanations for apparent gaps in the quality of rheumatology care: Results from the US Medicare Physician Quality Reporting System.  65:235-243. 2013
  • Preferences for arthritis interventions: Identifying similarities and differences among African Americans and whites with osteoarthritis.  65:203-211. 2013
  • Choosing wisely: The American College of Rheumatology's top 5 list of things physicians and patients should question.  65:329-339. 2013
  • Patient race and surgical outcomes after total knee arthroplasty: an analysis of a large regional database..  65:414-420. 2013
  • Trends in the use of biologic agents among rheumatoid arthritis patients enrolled in the US medicare program.  65:1743-1751. 2013
  • Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data.  64:1855-1863. 2012
  • Factors associated with gastrointestinal perforation in a cohort of patients with rheumatoid arthritis.  64:1819-1828. 2012
  • Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis.  64:1804-1810. 2012
  • Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity.  64:1794-1803. 2012
  • 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis..  64:1447-1461. 2012
  • 2012 American college of rheumatology guidelines for management of gout. part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.  64:1431-1446. 2012
  • Reply.  64:1623-1624. 2012
  • Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study.  64:1462-1470. 2012
  • Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high-versus lower-risk rheumatoid arthritis patients.  64:1480-1489. 2012
  • Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy.  64:1282-1291. 2012
  • Adherence with intravenous zoledronate and intravenous ibandronate in the United States medicare population.  64:1054-1060. 2012
  • Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis.  64:1001-1010. 2012
  • Patterns of compartment involvement in tibiofemoral osteoarthritis in men and women and in whites and African Americans.  64:847-852. 2012
  • Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort..  64:704-712. 2012
  • Predicting future response to certolizumab pegol in rheumatoid arthritis patients: features at 12 weeks associated with low disease activity at 1 year..  64:658-667. 2012
  • Rheumatoid arthritis disease activity measures: American college of rheumatology recommendations for use in clinical practice.  64:640-647. 2012
  • Incidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseases.  64:612-615. 2012
  • 2012 update of the 2008 American college of rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.  64:625-639. 2012
  • Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort.  64:132-137. 2012
  • Reply.  64:157-158. 2012
  • When it hurts, a positive attitude may help: Association of positive affect with daily walking in knee osteoarthritis. Results from a multicenter longitudinal cohort study.  64:1312-1319. 2012
  • Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice.  63:1680-1690. 2011
  • Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: Experience from a large US cohort.  63:1672-1679. 2011
  • Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States.  63:1642-1653. 2011
  • Association of peptic ulcer disease and pulmonary disease with risk of periprosthetic fracture after primary total knee arthroplasty.  63:1471-1476. 2011
  • Changes in cotherapies after initiation of disease - Modifying antirheumatic drug therapy in patients with rheumatoid arthritis.  63:1415-1424. 2011
  • Quadriceps weakness, patella alta, and structural features of patellofemoral osteoarthritis.  63:1391-1397. 2011
  • Smoking as a risk factor for short-term outcomes following primary total hip and total knee replacement in veterans.  63:1365-1374. 2011
  • Reply.  63:1355. 2011
  • Reply.  63:1353. 2011
  • Decreased live births in women with systemic lupus erythematosus.  63:1068-1072. 2011
  • Disparities in post-acute rehabilitation care for joint replacement.  63:1020-1030. 2011
  • Patient understanding and satisfaction in informed consent for total knee arthroplasty: A randomized study.  63:1048-1054. 2011
  • Estimation of minimum clinically important difference for pain in fibromyalgia.  63:821-826. 2011
  • 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features..  63:465-482. 2011
  • Defining quality of care in rheumatology: The American College of rheumatology white paper on quality measurement.  63:2-9. 2011
  • Measuring process of arthritis care: A proposed set of quality measures for the process of care in juvenile idiopathic arthritis.  63:10-16. 2011
  • Alpha 1-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis.  62:3760-3767. 2010
  • Associations of cigarette smoking with rheumatoid arthritis in African Americans.  62:3560-3568. 2010
  • Most common single-nucleotide polymorphisms associated with rheumatoid arthritis in persons of European ancestry confer risk of rheumatoid arthritis in African Americans.  62:3547-3553. 2010
  • Converting modified Health Assessment Questionnaire (HAQ), multidimensional HAQ, and HAQII scores into original HAQ scores using models developed with a large cohort of rheumatoid arthritis patients.  62:1481-1488. 2010
  • A national survey of veterans affairs rheumatologists for relevance of quality of care indicators for gout management.  62:1306-1311. 2010
  • The independent effect of pain in one versus two knees on the presence of low physical function in a multicenter knee osteoarthritis study.  62:938-943. 2010
  • Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus.  62:881-887. 2010
  • Radiographic severity of rheumatoid arthritis in African Americans: Results from a multicenter observational study.  62:624-631. 2010
  • Report of the American College of Rheumatology Pain Management Task Force.  62:590-599. 2010
  • Development and initial validation of a self-assessed lupus organ damage instrument.  62:559-568. 2010
  • Reply.  62:581. 2010
  • Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.  62:393-400. 2010
  • Physician preference motivates the use of anti-tumor necrosis factor therapy independent of clinical disease activity.  62:101-107. 2010
  • Value of assessing the fifth metatarsophalangeal joint in patients with early rheumatoid arthritis: Comment on the article by Sheane et al.  62:137. 2010
  • American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis..  62:1515-1526. 2010
  • Association between patella alta and the prevalence and worsening of structural features of patellofemoral joint osteoarthritis: The multicenter osteoarthritis study.  62:1258-1265. 2010
  • Do worsening knee radiographs mean greater chances of severe functional limitation?.  62:1433-1439. 2010
  • Cartilage loss occurs in the same subregions as subchondral bone attrition: A within-knee subregion-matched approach from the multicenter osteoarthritis study.  61:1539-1544. 2009
  • Reply.  61:1615-1616. 2009
  • Skeletal health among African Americans with recent-onset rheumatoid arthritis.  61:1379-1386. 2009
  • A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.  61:1168-1178. 2009
  • Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII.  61:1179-1186. 2009
  • Effect of thigh strength on incident radiographic and symptomatic knee osteoarthritis in a longitudinal cohort.  61:1210-1217. 2009
  • Novel evidence-based systemic lupus erythematosus responder index.  61:1143-1151. 2009
  • The effects of impaired joint position sense on the development and progression of pain and structural damage in knee osteoarthritis.  61:1070-1076. 2009
  • Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort.  61:830-839. 2009
  • Toward a Valid Definition of Gout Flare: Results of Consensus Exercises Using Delphi Methodology and Cognitive Mapping.  61:535-543. 2009
  • Is obesity a risk factor for progressive radiographic knee osteoarthritis?.  61:329-335. 2009
  • Rheumatology fellows' perception on training and careers in academia: The american college of rheumatology fellow research and academic training survey.  61:266-273. 2009
  • To the Editors.  61:285-286. 2009
  • Reply.  61:142. 2009
  • Optimal treatment of knee monarthritis in juvenile idiopathic arthritis: A decision analysis.  59:1580-1588. 2008
  • Association of body composition with disability in rheumatoid arthritis: Impact of appendicular fat and lean tissue mass.  59:1407-1415. 2008
  • Employment and disability issues in systemic lupus erythematosus: A review.  59:1475-1479. 2008
  • Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort.  59:1332-1340. 2008
  • Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: An American College of Rheumatology white paper.  59:1058-1073. 2008
  • Abnormal body composition phenotypes in older rheumatoid arthritis patients: Association with disease characteristics and pharmacotherapies.  59:807-815. 2008
  • American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.  59:762-784. 2008
  • Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis.  59:746-753. 2008
  • Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study.  59:721-729. 2008
  • Accumulation of coronary artery disease risk factors over three years: Data from an international inception cohort.  59:176-180. 2008
  • Association of health-related quality of life with dual use of prescription and over-the-counter nonsteroidal antiinflammatory drugs.  59:227-233. 2008
  • Comparison of Vancouver and International League of Associations for Rheumatology classification criteria for juvenile psoriatic arthritis.  59:51-58. 2008
  • Measurement of fatigue in systemic lupus erythematosus: A systematic review.  57:1348-1357. 2007
  • Racial/ethnic disparities in patient-reported nonsteroidal antiinflammatory drug (NSAID) risk awareness, patient-doctor NSAID risk communication, and NSAID risk behavior.  57:1539-1545. 2007
  • Absence of histologic evidence of synovitis in patients with Gulf War veterans' illness with joint pain.  57:1316-1323. 2007
  • Classification criteria in rheumatic diseases: A review of methodologie properties.  57:1119-1133. 2007
  • Using the short form 6D, as an overall measure of health, to predict damage accrual and mortality in patients with systemic lupus erythematosus: XLVII, results from a multiethnic US cohort.  57:986-992. 2007
  • Quality of care for gout in the US needs improvement.  57:822-829. 2007
  • A multiethnic, multicenter cohort of patients with Systemic Lupus Erythematosus (SLE) as a model for the study of ethnic disparities in SLE.  57:576-584. 2007
  • Accuracy of the diagnoses of spondylarthritides in veterans affairs medical center databases.  57:648-655. 2007
  • Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor α antagonists and disease-modifying antirheumatic drugs.  57:343-346. 2007
  • Contributions of OMERACT to rheumatic disease research [1].  57:186. 2007
  • Validity of gout diagnoses in administrative data.  57:103-108. 2007
  • Osteoporosis in the home health care setting: A window of opportunity?.  55:971-975. 2006
  • Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: Association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.  55:799-806. 2006
  • Development of classification and response criteria for rheumatic diseases.  55:348-352. 2006
  • Population-based assessment of adverse events associated with long-term glucocorticoid use.  55:420-426. 2006
  • Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis.  55:333-337. 2006
  • Race/ethnicity and cancer occurrence in systemic lupus erythematosus.  53:781-784. 2005
  • Are health care professionals advising adults with arthritis to become more physically active?.  53:279-283. 2005
  • Accuracy of veterans administration databases for a diagnosis of rheumatoid arthritis.  51:952-957. 2004
  • Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of criteria diagnosis.  51:609-615. 2004
  • Effect of knee osteoarthritis on the perception of quality of life in Venezuelan patients.  51:377-382. 2004
  • Measuring quality in arthritis care: The arthritis foundation's quality indicator set for analgesics.  51:337-349. 2004
  • Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course.  51:465-474. 2004
  • Measuring Quality in Arthritis Care: Methods for Developing the Arthritis Foundation's Quality Indicator Set.  51:193-202. 2004
  • Systemic Lupus Erythematosus in Three Ethnic Groups. XVIII. Factors Predictive of Poor Compliance with Study Visits.  51:258-263. 2004
  • Systemic Lupus Erythematosus in Three Ethnic Groups. XIV. Poverty, Wealth, and Their Influence on Disease Activity.  51:73-77. 2004
  • Leflunomide Use during the First 33 Months after Food and Drug Administration Approval: Experience with a National Cohort of 3,325 Patients.  49:745-751. 2003
  • The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs.  49:293-299. 2003
  • A reply to comments on sociocultural issues in clinical research: Unraveling the Tuskegee Syphilis Study [1].  47:691. 2002
  • Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: A comparison of physician and patient visual analog scale scores.  47:408-413. 2002
  • Systemic lupus erythematosus in three ethnic groups. X. Measuring cognitive impairment with the cognitive symptoms inventory.  47:310-319. 2002
  • Resolved: Low-dose glucocorticoids are neither safe nor effective for the long-term treatment of rheumatoid arthritis.  45:468-471. 2001
  • Sociocultural issues in clinical research.  45:203-207. 2001
  • Systemic lupus erythematosus in three ethnic groups. VIII. Predictors of early mortality in the LUMINA cohort.  45:191-202. 2001
  • Psychosocial and health status variables independently predict health care seeking in fibromyalgia.  45:362-371. 2001
  • Use of complementary and alternative medicine by older patients with arthritis: A population-based study.  45:398-403. 2001
  • Systemic lupus erythematosus in three ethnic groups. IV. Factors associated with self-reported functional outcome in a large cohort study.  12:256-266. 1999
  • Systemic lupus erythematosus in three ethnic groups. V. Acculturation, health-related attitudes and behaviors, and disease activity in hispanic patients from the LUMINA cohort.  12:267-276. 1999
  • Translation to Spanish, reproducibility, and cross-cultural adaptation of the Miller-Rahe recent life change questionnaire in Venezuela.  12:287-293. 1999